{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:17:19Z","timestamp":1757618239809,"version":"3.44.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ejmech.2025.118069","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T06:00:03Z","timestamp":1756101603000},"page":"118069","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design, synthesis, structure-activity relationship (SAR) and analgesic effect studies of novel arylsulfonamides as selective Nav1.7 inhibitors"],"prefix":"10.1016","volume":"299","author":[{"given":"Ruokun","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenfeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinran","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hang","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingmiao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongqiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118069_bib1","first-page":"253","article-title":"The VGL-chanome: a protein superfamily specialized for electrical signaling and ionic homeostasis","volume":"253","author":"Yu","year":"2004","journal-title":"Science's Signal Transduction Knowledge Environment"},{"issue":"4","key":"10.1016\/j.ejmech.2025.118069_bib2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1124\/pr.57.4.4","article-title":"International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels","volume":"57","author":"Catterall","year":"2005","journal-title":"Pharmacol. Rev."},{"issue":"9","key":"10.1016\/j.ejmech.2025.118069_bib3","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/j.bpj.2011.08.056","article-title":"Extracellular proton modulation of the cardiac voltage-gated sodium channel, Nav1.5","volume":"101","author":"Jones","year":"2011","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejmech.2025.118069_bib4","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.3389\/fphar.2020.01276","article-title":"Epilepsy-related voltage-gated sodium channelopathies: a review","volume":"11","author":"Menezes","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118069_bib5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1146\/annurev-neuro-070918-050144","article-title":"Sodium channels in human pain disorders: genetics and pharmacogenomics","volume":"42","author":"Dib-Hajj","year":"2019","journal-title":"Annu. Rev. Neurosci."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118069_bib6","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1152\/physrev.00025.2020","article-title":"Sodium channelopathies of skeletal muscle and brain","volume":"101","author":"Mantegazza","year":"2021","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejmech.2025.118069_bib7","first-page":"331","article-title":"Cardiac arrhythmias related to sodium channel dysfunction","volume":"246","author":"Savio-Galimberti","year":"2018","journal-title":"Metabolic Control"},{"issue":"6058","key":"10.1016\/j.ejmech.2025.118069_bib8","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/320188a0","article-title":"Existence of distinct sodium channel messenger RNAs in rat brain","volume":"320","author":"Noda","year":"1986","journal-title":"Nature"},{"issue":"7356","key":"10.1016\/j.ejmech.2025.118069_bib9","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nature10238","article-title":"The crystal structure of a voltage-gated sodium channel","volume":"475","author":"Payandeh","year":"2011","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ejmech.2025.118069_bib10","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.cell.2017.06.039","article-title":"Structure of the Nav1.4-\u03b21 complex from electric eel","volume":"170","author":"Yan","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118069_bib11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0896-6273(00)81133-2","article-title":"From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels","volume":"26","author":"Catterall","year":"2000","journal-title":"Neuron"},{"issue":"12","key":"10.1016\/j.ejmech.2025.118069_bib12","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/s41594-022-00860-1","article-title":"Structural basis for NaV1.7 inhibition by pore blockers","volume":"29","author":"Zhang","year":"2022","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ejmech.2025.118069_bib13","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00424-020-02419-9","article-title":"Painful and painless mutations of SCN9A and SCN11A voltage-gated sodium channels","volume":"472","author":"Baker","year":"2020","journal-title":"Pflueg. Arch. Eur. J. Physiol."},{"issue":"7121","key":"10.1016\/j.ejmech.2025.118069_bib14","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature05413","article-title":"An SCN9A channelopathy causes congenital inability to experience pain","volume":"444","author":"Cox","year":"2006","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ejmech.2025.118069_bib15","doi-asserted-by":"crossref","first-page":"432","DOI":"10.4239\/wjd.v6.i3.432","article-title":"Diabetic neuropathic pain: physiopathology and treatment","volume":"6","author":"Schreiber","year":"2015","journal-title":"World J. Diabetes"},{"issue":"3","key":"10.1016\/j.ejmech.2025.118069_bib16","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/ana.20776","article-title":"Sporadic onset of erythermalgia: a gain\u2010of\u2010function mutation in Nav1.7","volume":"59","author":"Han","year":"2006","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118069_bib17","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1399-0004.2007.00790.x","article-title":"Loss\u2010of\u2010function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations","volume":"71","author":"Goldberg","year":"2007","journal-title":"Clin. Genet."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118069_bib18","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/ncomms1795","article-title":"Distinct Nav1.7-dependent pain sensations require different sets of sensory and sympathetic neurons","volume":"3","author":"Minett","year":"2012","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.ejmech.2025.118069_bib19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pain.2007.07.026","article-title":"The roles of sodium channels in nociception: implications for mechanisms of pain","volume":"131","author":"Cummins","year":"2007","journal-title":"Pain"},{"issue":"8","key":"10.1016\/j.ejmech.2025.118069_bib20","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/s41401-021-00682-9","article-title":"Inhibition of Nav1.7 channel by a novel blocker QLS-81 for alleviation of neuropathic pain","volume":"42","author":"Niu","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"issue":"8","key":"10.1016\/j.ejmech.2025.118069_bib21","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.1021\/acs.jmedchem.9b00141","article-title":"Structure-and ligand-based discovery of chromane arylsulfonamide Nav1.7 inhibitors for the treatment of chronic pain","volume":"62","author":"McKerrall","year":"2019","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118069_bib22","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1021\/acs.jmedchem.8b01550","article-title":"Discovery of indole-and indazole-acylsulfonamides as potent and selective NaV1.7 inhibitors for the treatment of pain","volume":"62","author":"Luo","year":"2018","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118069_bib23","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1021\/acs.jmedchem.8b01621","article-title":"Identification of selective acyl sulfonamide\u2013cycloalkylether inhibitors of the voltage-gated sodium channel (NaV)1.7 with potent analgesic activity","volume":"62","author":"Sun","year":"2018","journal-title":"J. Med. Chem."},{"issue":"6267","key":"10.1016\/j.ejmech.2025.118069_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/science.aac5464","article-title":"Structural basis of Nav1.7 inhibition by an isoform-selective small-molecule antagonist","volume":"350","author":"Ahuja","year":"2015","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118069_bib25","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1038\/s41467-023-38942-3","article-title":"Structural mapping of Nav1. 7 antagonists","volume":"14","author":"Wu","year":"2023","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.ejmech.2025.118069_bib26","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/j.pain.0000000000001227","article-title":"Efficacy of the Nav1.7 blocker PF-05089771 in a randomised, placebo-controlled, double-blind clinical study in subjects with painful diabetic peripheral neuropathy","volume":"159","author":"McDonnell","year":"2018","journal-title":"Pain"},{"key":"10.1016\/j.ejmech.2025.118069_bib27","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.84151","article-title":"Cryo-EM reveals an unprecedented binding site for NaV1.7 inhibitors enabling rational design of potent hybrid inhibitors","volume":"12","author":"Kschonsak","year":"2023","journal-title":"eLife"},{"issue":"16","key":"10.1016\/j.ejmech.2025.118069_bib28","doi-asserted-by":"crossref","first-page":"7029","DOI":"10.1021\/acs.jmedchem.7b00598","article-title":"Discovery of clinical candidate 4-[2-(5-amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): design and optimization of diaryl ether aryl sulfonamides as selective inhibitors of NaV1.7","volume":"60","author":"Swain","year":"2017","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2025.118069_bib29","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1021\/acs.jmedchem.1c00049","article-title":"Discovery of acyl-sulfonamide NaV1.7 inhibitors GDC-0276 and GDC-0310","volume":"64","author":"Safina","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118069_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejphar.2018.01.041","article-title":"Effects of ralfinamide in models of nerve injury and chemotherapy-induced neuropathic pain","volume":"823","author":"Liang","year":"2018","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.ejmech.2025.118069_bib31","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1172\/JCI25466","article-title":"Sodium channel mutations in epilepsy and other neurological disorders","volume":"115","author":"Meisler","year":"2005","journal-title":"J. Clin. Investig."},{"issue":"3","key":"10.1016\/j.ejmech.2025.118069_bib32","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pain.2003.12.035","article-title":"Changes in the expression of tetrodotoxin-sensitive sodium channels within dorsal root ganglia neurons in inflammatory pain","volume":"108","author":"Black","year":"2004","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.ejmech.2025.118069_bib33","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/med.21445","article-title":"Development of safe drugs: the hERG challenge","volume":"38","author":"Kalyaanamoorthy","year":"2018","journal-title":"Med. Res. Rev."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425008347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425008347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T17:40:39Z","timestamp":1757180439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425008347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":33,"alternative-id":["S0223523425008347"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118069","relation":{},"ISSN":["0223-5234"],"issn-type":[{"type":"print","value":"0223-5234"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, structure-activity relationship (SAR) and analgesic effect studies of novel arylsulfonamides as selective Nav1.7 inhibitors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118069"}}